Vascular Endothelial Growth Factor Inhibitor-Induced Hypertension: Basics for Primary Care Providers
Saved in:
| Main Authors: | Carmen P. Escalante, Ali Zalpour |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Cardiology Research and Practice |
| Online Access: | http://dx.doi.org/10.4061/2011/816897 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vascular endothelial growth factor inhibitors in the treatment of ovarian cancer
by: S. V. Khokhlova
Published: (2014-08-01) -
The Use of Vascular Endothelial Growth Factor Inhibitors in Patients with Proliferative Diabetic Retinopathy
by: V. Yu. Evgrafov, et al.
Published: (2022-07-01) -
Vascular Endothelial Growth Factor (VEGF) Family and the Immune System: Activators or Inhibitors?
by: Cristina Maria Failla, et al.
Published: (2024-12-01) -
Endothelial CHOP as a central mechanism in renovascular hypertension-induced vascular endothelial dysfunction and cardiac fibrosis
by: B. Srinivas, et al.
Published: (2025-06-01) -
Effect of the Vascular Endothelial Growth Factor Inhibitor Toceranib on Cardiac Function and Endothelial Dysfunction Biomarkers in Dogs With Cancer
by: Katherine E. Lopez, et al.
Published: (2025-05-01)